Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
IQV
IQVIA Inc€711
1USOA
Jun 10, 2020
currency
EUR
size (m)
711.000
maturity
Jun 15, 2028
type
Fixed
tenor
8.000
call
3
registration
144A/Reg S
benchmark
-
ranking
-
moody's
Ba3
s&p
BB
fitch
-
size description
-
re-open/tap
No
ipt
-
ipt-pxd
-
guidance
3.00% area
spread
330
coupon
2.875%
spread set
-
price
100.00000
yield
2.875%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
BBV, BNP, BRC, CTI, ...
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
BBV, BNP, BRC, CTI, ...
coordinating managers
-
Tranche Comments
Registration: 144A/Reg S; Comments: 06/10/2020 IQVIA Inc (IQV) EUR711m (approx $800m equivalent) 144A/Reg S sr notes due June 15, 2028 (8y). NC3 (MWC B+50bp), then at 101.438, 100.719, 100. Equity claw: 3y 40% at 102.875. Ba3/BB (stable/stable). Via GS (B&D)/BofA/HSBC/JPM/PNC joint books, Barc, WFS, Citi, FITB, MIzuho, MUFG, STRH, TD, BBVA, BNPP, Huntington, RBC, Siebert as co-managers. No reg rights. New York law. List TISE. Settles June 24 (T+10). Reg S ISIN: XS218994705. Px talk: 3.00% area. Priced: 2.875% at 100. +330bp vs DBR 0.25% 08/15/28. Did investor call at 2:30pm UKT (9:30am NYT) 06/09. Books closed: US at 5:30pm NYT 06/09, Europe at 10:30am UKT 06/10. UOP: redeem its EUR625m 3.50% sr notes due 2024 (callable at 101.75), partially pay down revolver. Biz: a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. HQ: Danbury, CT.;

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.